SBRT Plus Lenalidomide for Solitary Plasmacytoma: Phase II Trial
Clinical trial NCT06863584 · RECRUITING
Trial details
- NCT number
- NCT06863584
- Sponsor
- Second Affiliated Hospital, Zhejiang University, School of Medicine
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-02-10
- Primary completion
- 2027-03-31
- Enrollment
- 41
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.